Atara Biotherapeutics Statistics

Total Valuation

ATRA has a market cap or net worth of $38.93 million. The enterprise value is $42.70 million.

Market Cap	38.93M
Enterprise Value	42.70M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, before market open.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

ATRA has 8.18 million shares outstanding. The number of shares has increased by 69.85% in one year.

Current Share Class	8.18M
Shares Outstanding	8.18M
Shares Change (YoY)	+69.85%
Shares Change (QoQ)	+0.42%
Owned by Insiders (%)	2.41%
Owned by Institutions (%)	27.72%
Float	5.33M

Valuation Ratios

The trailing PE ratio is 1.85.

PE Ratio	1.85
Forward PE	n/a
PS Ratio	0.34
Forward PS	2.37
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	1.31
EV / Sales	0.35
EV / EBITDA	0.83
EV / EBIT	0.86
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.82

Current Ratio	0.82
Quick Ratio	0.65
Debt / Equity	n/a
Debt / EBITDA	0.18
Debt / FCF	n/a
Interest Coverage	13.05

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	47.81%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	931.13%
Weighted Average Cost of Capital (WACC)	9.33%
Revenue Per Employee	$8.63M
Profits Per Employee	$2.33M
Employee Count	14
Asset Turnover	1.87
Inventory Turnover	n/a

Taxes

In the past 12 months, ATRA has paid $31,000 in taxes.

Income Tax	31,000
Effective Tax Rate	0.09%

Stock Price Statistics

The stock price has decreased by -34.97% in the last 52 weeks. The beta is -0.33, so ATRA's price volatility has been lower than the market average.

Beta (5Y)	-0.33
52-Week Price Change	-34.97%
50-Day Moving Average	5.08
200-Day Moving Average	10.44
Relative Strength Index (RSI)	43.55
Average Volume (20 Days)	64,228

Short Selling Information

The latest short interest is 317,953, so 3.89% of the outstanding shares have been sold short.

Short Interest	317,953
Short Previous Month	327,066
Short % of Shares Out	3.89%
Short % of Float	5.96%
Short Ratio (days to cover)	3.32

Income Statement

In the last 12 months, ATRA had revenue of $120.77 million and earned $32.69 million in profits. Earnings per share was $2.57.

Revenue	120.77M
Gross Profit	74.62M
Operating Income	49.47M
Pretax Income	32.72M
Net Income	32.69M
EBITDA	51.59M
EBIT	49.47M
Earnings Per Share (EPS)	$2.57

Full Income Statement

Balance Sheet

The company has $8.48 million in cash and $10.38 million in debt, giving a net cash position of -$1.89 million or -$0.23 per share.

Cash & Cash Equivalents	8.48M
Total Debt	10.38M
Net Cash	-1.89M
Net Cash Per Share	-$0.23
Equity (Book Value)	-38.50M
Book Value Per Share	-5.26
Working Capital	-2.71M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-50.94M
Capital Expenditures	n/a
Depreciation & Amortization	2.12M
Net Borrowing	-250,000
Free Cash Flow	-50.94M
FCF Per Share	-$6.23

Full Cash Flow Statement

Margins

Gross margin is 61.79%, with operating and profit margins of 40.96% and 27.07%.

Gross Margin	61.79%
Operating Margin	40.96%
Pretax Margin	27.09%
Profit Margin	27.07%
EBITDA Margin	42.71%
EBIT Margin	40.96%
FCF Margin	n/a

Dividends & Yields

ATRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-69.85%
Shareholder Yield	-69.85%
Earnings Yield	80.10%
FCF Yield	-124.83%

Analyst Forecast

The average price target for ATRA is $5.00, which is 5.04% higher than the current price. The consensus rating is "Sell".

Price Target	$5.00
Price Target Difference	5.04%
Analyst Consensus	Sell
Analyst Count	2
Revenue Growth Forecast (5Y)	0.76%
EPS Growth Forecast (5Y)	-3.58%

Stock Forecasts

Stock Splits

The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date	Jun 20, 2024
Split Type	Reverse
Split Ratio	1:25

Scores

ATRA has an Altman Z-Score of -125.28 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-125.28
Piotroski F-Score	5